The Warfarin Sodium Tablets, cataloged under National Stock Number 6505-01-049-1815, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Bristol-Myers Squibb Pharma Company. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 4 commercial cross-references from 2 manufacturers, enabling identification through both NSN and commercial part number lookups. 5 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Cancelled. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-049-1815 |
| Primary Part Number | NDC00056-0174-75 |
| Item Name | Warfarin Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Bristol-Myers Squibb Pharma Company |
| Status | CANCELLED |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | INDIVIDUALLY SEALED |
| Primary Container Type | STRIP |
| Primary Container Content Quantity | 100.000 TABLETS |
| Active Medicament Medicinal Strength | 10.000 MILLIGRAMS WARFARIN SODIUM ACTIVE INGREDIENT |
| Acquisition Status | CANCELLED |
| HAZMAT | No |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| COUMADIN TABLETS | Bristol-Myers Squibb Company Dba Bristol-Myers Squibb (USA) |
| COUMADIN | Bristol-Myers Squibb Company Dba Bristol-Myers Squibb (USA) |
| NDC00056-0174-75 | Bristol-Myers Squibb Company Dba Bristol-Myers Squibb (USA) |
| NDC00056-0174-75 PRIMARY | Bristol-Myers Squibb Pharma Company (USA) |
NSN 6505-01-049-1815 is a Warfarin Sodium Tablets, manufactured by Bristol-Myers Squibb Pharma Company, classified under FSC 6505 (No Item Name Available). Status: cancelled.
NSN 6505-01-049-1815 has 4 cross-referenced part numbers: COUMADIN TABLETS (Bristol-Myers Squibb Company Dba Bristol-Myers Squibb), COUMADIN (Bristol-Myers Squibb Company Dba Bristol-Myers Squibb), NDC00056-0174-75 (Bristol-Myers Squibb Company Dba Bristol-Myers Squibb), NDC00056-0174-75 (Bristol-Myers Squibb Pharma Company).
There are 5 known substitutes for 6505-01-049-1815: 6505-00-973-8502, 6505-00-982-4230, 6505-01-052-2857 and 2 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00056-0174-75: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Part Name Assigned by Controlling Agency: WARFARIN SODIUM TABLETS USP 10MG ORAL 100S; Features Provided: INDIVIDUALLY SEALED; Primary Container Type: STRIP. 6 total characteristics are documented in the Federal Logistics Information System.
NSN 6505-01-049-1815 is currently cancelled. Check with the Defense Logistics Agency for current availability and authorized substitutes.